Literature DB >> 7870967

Are patterns of benzodiazepine use predictable? A follow-up study of benzodiazepine users.

C Barnas1, A B Whitworth, W W Fleischhacker.   

Abstract

A sample of 171 patients taking benzodiazepines (BZDs) who had been investigated in 1988 was followed up in 1991. From 140 patients who were still alive and willing to participate, 25% had stopped BZDs after an average duration of intake of 34 months. Of the 105 persons still taking a BZD, 37% were taking the same dose, 26% had reduced the dose and 37% had increased it. Characteristics of BZD long-term users and patients potentially at risk for abuse and/or dependence that were established from the 1988 data were reexamined: patients with continued BZD use more often suffered from somatic illness which often had deteriorated, they had a longer duration of intake and used higher daily doses. In most cases the indication was insomnia. Patients with a clinically relevant dose increase were more often males, frequently found to be dependent on alcohol and/or illegal drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870967     DOI: 10.1007/bf02244945

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Patients, prescribing, and benzodiazepines.

Authors:  L Nolan; K O'Malley
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Psychotropic drug use in a representative community sample: the Upper Bavarian study.

Authors:  M M Fichter; W Witzke; K Leibl; H Hippius
Journal:  Acta Psychiatr Scand       Date:  1989-07       Impact factor: 6.392

3.  Cross-national study of the extent of anti-anxiety-sedative drug use.

Authors:  M B Balter; J Levine; D I Manheimer
Journal:  N Engl J Med       Date:  1974-04-04       Impact factor: 91.245

4.  Characteristics of benzodiazepine long-term users: investigation of benzodiazepine consumers among pharmacy customers.

Authors:  C Barnas; W W Fleischhacker; A B Whitworth; P Schett; C Stuppäck; H Hinterhuber
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  One year follow-up of users of benzodiazepines in general practice.

Authors:  M Holm
Journal:  Dan Med Bull       Date:  1990-04

6.  Psychotropic drug utilization patterns in a metropolitan population.

Authors:  W Koenig; E Rüther; B Filipiak
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Audit and follow-up of chronic benzodiazepine tranquillizer use in one general practice.

Authors:  J M Morrison
Journal:  Fam Pract       Date:  1990-12       Impact factor: 2.267

8.  Long-term diazepam therapy and clinical outcome.

Authors:  K Rickels; W G Case; R W Downing; A Winokur
Journal:  JAMA       Date:  1983-08-12       Impact factor: 56.272

9.  Mortality of patients dependent on benzodiazepines.

Authors:  B Piesiur-Strehlow; U Strehlow; W Poser
Journal:  Acta Psychiatr Scand       Date:  1986-03       Impact factor: 6.392

10.  Prescription and misuse of benzodiazepines in the Federal Republic of Germany.

Authors:  B Müller-Oerlinghausen
Journal:  Pharmacopsychiatry       Date:  1986-01       Impact factor: 5.788

  10 in total
  3 in total

1.  Commentary on review by Woods and Winger. Benzodiazepines: long-term use among patients is a concern and abuse among polydrug abusers is not trivial.

Authors:  R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

2.  Determinants of chronic benzodiazepine use in the elderly: a longitudinal study.

Authors:  Hendrika J Luijendijk; Henning Tiemeier; Albert Hofman; Jan Heeringa; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

Review 3.  Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.

Authors:  Amber N Edinoff; Catherine A Nix; Amira S Odisho; Caroline P Babin; Alyssa G Derouen; Salim C Lutfallah; Elyse M Cornett; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Neurol Int       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.